EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prediction of long-term mortality in acute hypercapnic respiratory failure with use of low-flow veno-venous extracorporeal CO2 removal (ECCO2R): A retrospective single-center study

Anne-Aylin Sigg, Stefanie Keiser, Shalimar Mila Konopasek, Stephanie Klinzing, Pedro David Wendel-Garcia, Marco Maggiorini, Reto Andreas Schuepbach, Matthias Peter Hilty

Blood Purification · 2026

DOI: 10.1159/000550776 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood Purification, 2026. Verfasst von Anne-Aylin Sigg und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Intensive Care Medicine, University Hospital of Zurich, Zurich, Switzerland, anne-aylin.sigg@usz.ch. Hauptthemen laut MEDLINE: Carbon Dioxide, Respiratory Insufficiency, Extracorporeal Membrane Oxygenation, Hypercapnia. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Hypercapnic respiratory failure is associated with high morbidity and mortality. Low-flow extracorporeal CO2 removal (ECCO2R) has been shown to facilitate lung protective ventilation or spontaneous breathing. However, three multicenter randomized trials have failed to show benefit which could potentially be a result of patient selection. In this study, we aimed to characterize prognostic scores developed for extracorporeal membrane oxygenation therapy which could potentially assist with the selection of patients for ECCO2R.

Methods

70 patients admitted to the ICU at the University Hospital of Zurich between 10/2009 and 02/2017 with hypercapnic respiratory failure were treated with ECCO2R if pH ≤ 7.25 and/or PaCO2 ≥ 9kPa experiencing respiratory exhaustion during spontaneous breathing in obstructive lung disease or reaching the limits of lung protective ventilation (n=22 and n=48) in patients with restrictive lung pathologies. Data including baseline characteristics and respiratory parameters were collected prospectively. Scores were calculated retrospectively.

Results

The underlying diseases were ARDS (n=27), COPD (n=12), bronchiolitis obliterans syndrome (n=9), cystic fibrosis (n=10), pulmonary fibrosis (n=8) and other causes (n=4). 180-day mortality was 45.7% with the highest rate observed in PF and BOS patients as well as in patients who had been mechanically ventilated > 6 days before initiation of ECCO2R. The modified PRedicting dEath for SEvere hypercapnic Respiratory failure on vv-ECCO2R (PRESERVE-CO2) score differentiated well between survivors and non-survivors (4.3 ± 2.2 vs 6.9 ± 2.6, p < 0.01), whereas the modified Respiratory ECMO Survival Prediction (RESP-CO2) score showed no significant distinction. Receiver operating characteristics analysis of the PRESERVE-CO2 score revealed an area under the curve of 0.78, suggesting a cut-off of 7 points.

Conclusion

Careful selection of patients for ECCO2R therapy may help to improve outcomes. The proposed PRESERVE-CO2 score may serve as a guide. A score of 7 points or higher is associated with an unfavorable outcome regarding the 180-day mortality in the specific patient cohort of this study, but future studies to externally validate this score are required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carbon DioxideRespiratory InsufficiencyExtracorporeal Membrane OxygenationHypercapniaHumansRetrospective StudiesFemaleMaleMiddle AgedAdultPrognosisAged

Stichwörter der Autor:innen

Acute respiratory distress syndromeChronic-obstructive pulmonary diseaseCystic fibrosisExtracorporeal CO2 removalHypercapniaOutcome

Substanzen

Carbon Dioxide

Autor:innen und Institutionen

  • Institute of Intensive Care Medicine, University Hospital of Zurich, Zurich, Switzerland, anne-aylin.sigg@usz.ch.
  • Institute of Intensive Care Medicine, University Hospital of Zurich, Zurich, Switzerland.

Zitieren

APA

Sigg, A. A., Keiser, S., Konopasek, S. M., Klinzing, S., Wendel-Garcia, P. D., Maggiorini, M., Schuepbach, R. A., & Hilty, M. P. (2026). Prediction of long-term mortality in acute hypercapnic respiratory failure with use of low-flow veno-venous extracorporeal CO2 removal (ECCO2R): A retrospective single-center study. Blood Purification. https://doi.org/10.1159/000550776

Vancouver

Sigg AA, Keiser S, Konopasek SM, Klinzing S, Wendel-Garcia PD, Maggiorini M, et al. Prediction of long-term mortality in acute hypercapnic respiratory failure with use of low-flow veno-venous extracorporeal CO2 removal (ECCO2R): A retrospective single-center study. Blood Purification. 2026. doi:10.1159/000550776

BibTeX
@article{Sigg2026,
  author = {Sigg, Anne-Aylin and Keiser, Stefanie and Konopasek, Shalimar Mila and Klinzing, Stephanie and Wendel-Garcia, Pedro David and Maggiorini, Marco and Schuepbach, Reto Andreas and Hilty, Matthias Peter},
  title = {Prediction of long-term mortality in acute hypercapnic respiratory failure with use of low-flow veno-venous extracorporeal CO2 removal (ECCO2R): A retrospective single-center study},
  journal = {Blood Purification},
  year = {2026},
  doi = {10.1159/000550776}
}
Kostenlos starten →